WFI
REGN icon

West Family Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

West Family Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$634K Buy
1,017
+423
+71% +$288K 0.18% 131
2026
Q1 		$459K Sell
594
-192
-24% -$147K 0.16% 116
2025
Q4 		$607K Sell
786
-179
-19% -$122K 0.14% 137
2025
Q3 		$543K Sell
965
-12
-1% -$6.79K 0.12% 161
2025
Q2 		$513K Sell
977
-160
-14% -$89.3K 0.13% 155
2025
Q1 		$721K Hold
1,137
– – 0.27% 76
2024
Q4 		$810K Sell
1,137
-53
-4% -$44.5K 0.28% 71
2024
Q3 		$1.25M Buy
1,190
+5
+0.4% +$5.56K 0.43% 48
2024
Q2 		$1.25M Buy
1,185
+2
+0.2% +$1.94K 0.37% 55
2024
Q1 		$1.14M Buy
1,183
+46
+4% +$43.7K 0.35% 58
2023
Q4 		$999K Hold
1,137
– – 0.34% 60
2023
Q3 		$936K Sell
1,137
-204
-15% -$160K 0.33% 63
2023
Q2 		$964K Hold
1,341
– – 0.37% 60
2023
Q1 		$1.1M Sell
1,341
-30
-2% -$22.6K 0.44% 58
2022
Q4 		$989K Sell
1,371
-198
-13% -$146K 0.34% 63
2022
Q3 		$1.08M Sell
1,569
-71
-4% -$44.7K 0.45% 49
2022
Q2 		$969K Sell
1,640
-171
-9% -$111K 0.38% 54
2022
Q1 		$1.26M Sell
1,811
-17
-0.9% -$10.8K 0.36% 49
2021
Q4 		$1.15M Sell
1,828
-204
-10% -$125K 0.31% 57
2021
Q3 		$1.23M Buy
2,032
+228
+13% +$142K 0.32% 55
2021
Q2 		$1.01M Buy
+1,804
New +$914K 0.27% 55

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

West Family Investments's REGN Position: Q2 2026 in Review

West Family Investments increased its Regeneron Pharmaceuticals (REGN) stake by 71% in Q2 2026, buying an estimated $288K and bringing the position to 1,017 shares worth $634K. The position accounts for 0.18% of the portfolio, ranked #131.

West Family Investments first reported a position in REGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.26M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • West Family Investments held 1,017 shares of Regeneron Pharmaceuticals worth $634K as of Q2 2026.
  • West Family Investments bought 423 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $288K.
  • Regeneron Pharmaceuticals made up 0.18% of West Family Investments's portfolio in Q2 2026, its #131 holding.
  • West Family Investments first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • West Family Investments's Regeneron Pharmaceuticals position peaked at $1.26M in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on West Family Investments's 13F filing for Q2 2026, filed 10 Aug 2026.